Volume 58, Issue 7 pp. 730-736
Research Article

Silicosis and chronic renal disease

Melissa L. Millerick-May MS, PhD

Corresponding Author

Melissa L. Millerick-May MS, PhD

Department of Medicine, College of Human Medicine, Michigan State University, East Lansing, Michigan

Correspondence to: Melissa L. Millerick-May, MS, PhD, Department of Medicine, College of Human Medicine, Michigan State University, 909 Fee Rd. Room 120 West Fee Hall, East Lansing, MI 48824, USA. E-mail: [email protected]

Search for more papers by this author
Sarah Schrauben MD

Sarah Schrauben MD

Division of Renal, Electrolyte and Hypertension, University of Pennsylvania Health System, Philadelphia, Pennsylvania

Search for more papers by this author
Mary Jo Reilly MS

Mary Jo Reilly MS

Department of Medicine, College of Human Medicine, Michigan State University, East Lansing, Michigan

Search for more papers by this author
Kenneth D. Rosenman MD

Kenneth D. Rosenman MD

Department of Medicine, College of Human Medicine, Michigan State University, East Lansing, Michigan

Search for more papers by this author
First published: 04 May 2015
Citations: 18
Work was performed at the Division of Occupational and Environmental Medicine, Department of Medicine, Michigan State University.
Conflict of Interest: Melissa L. Millerick-May, Sarah Schrauben, and Mary Jo Reilly declare no competing interests/conflicts of interest. Kenneth D. Rosenman has been an expert witness for patients applying for worker compensation.
Author Contributions: KD Rosenman and MJ Reilly participated in the design of the study. S. Schrauben collected/abstracted data. ML Millerick-May, KD Rosenman analyzed and interpreted the data. All authors participated in the development of initial and subsequent drafts of the manuscript, including approval of the final version to be published.
Ethics Review/Approval: This investigation was approved by the Michigan State University Human Research Protection Program (Biomedical and Health IRB).

Abstract

Background

Silica has been associated with end stage kidney disease and kidney dysfunction.

Methods

Calculated glomerular filtration rate, history of kidney disease or chronic dialysis, elevated serum creatinine, and stages of chronic kidney disease among silicotics identified in Michigan's Silicosis Surveillance System from 1987 to 2009 were reviewed to determine the prevalence of kidney disease in confirmed cases of silicosis.

Results

Twenty-four percent of 1,072 silicotics had a measure of kidney dysfunction (32.3% if diabetes or hypertension present vs. 20.2% if not). Sixty-nine percent of silicotics had Stage I or greater chronic kidney dysfunction versus 38.8% of the U.S. general population ≥60 years. No association was found between kidney function and measures of silica exposure.

Conclusions

Individuals with silicosis have an increased prevalence of kidney disease. More work to define the pathological changes associated with silica exposure is needed to understand the cause of silica's adverse effect on the kidney. Am. J. Ind. Med. 58:730–736, 2015. © 2015 Wiley Periodicals, Inc.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.